Off‐label drug use in neonates and infants in Spain: A five‐year observational study
Open Access
- 9 September 2021
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 31 (3) , 270-282
Abstract
Objectives: To provide information about the off‐label rate of all drug prescriptions in neonates and infants up to 1 year in Spain. Also, to analyse the off‐label prescription of medicines under current practice in this age group according to different evidence sources.Study design: A five‐year (2015–2019) exploratory observational study about off‐label prescription in neonates and infants (0 to 1 year) at primary health care in Spain. All drug prescriptions in this age group were analysed and classified according to their labelling in off‐label or on‐label. The drugs prescribed off‐label were subsequently reviewed in national formularies and other databases to assess its evidence of use beyond what is recommended in the Summary of Product Characteristics (SmPC).Results: On average 34.50% of total prescriptions were prescribed off‐label according to the SmPC. 17.93% of total prescriptions in neonates and infants up to 1 year old were not based on clinical evidence from SmPC, Pediamécum, BNF or DailyMed. In more than 88% of cases, off‐label use was related to the posology section of the SmPC, followed by the therapeutic indications and contraindications sections, in 35.20% and 24.10% of cases, respectively. Almost 13% of off‐label drugs were over‐the‐counter. Salbutamol followed by topical tobramycin and colecalciferol were the drugs most prescribed off‐label.Conclusions: Off‐label use of drugs remains as an important public health concern, especially for neonates and infants up to 1 year, who receive the greatest proportion of off‐label prescriptions. The evidence‐based off‐label prescription is a widespread practice that has shown a stable trend during the 5‐year study period providing also a certain extent of flexibility to paediatricians in some therapeutic decisions.Keywords
This publication has 22 references indexed in Scilit:
- Trends in Prescription Medication Use Among Children and Adolescents—United States, 1999-2014JAMA, 2018
- Variabilidad e idoneidad del tratamiento antiasmático en pediatría de atención primariaAtencion Primaria, 2017
- Vitamin D in European children—statement from the European Academy of Paediatrics (EAP)European Journal of Pediatrics, 2017
- Utilización de medicamentos en condiciones off-label y unlicensed : resultados de un estudio piloto realizado en una unidad de cuidados intensivos pediátricosAnales de Pediatría, 2017
- Off-Label Prescribing in Pediatric OutpatientsPediatrics, 2015
- Conocimiento sobre el uso de fármacos off-label en Pediatría. Resultados de una encuesta pediátrica nacional 2012-2013 (estudio OL-PED)Anales de Pediatría, 2014
- Adverse drug reactions and off-label and unlicensed medicines in children: a nested case?control study of inpatients in a pediatric hospitalBMC Medicine, 2013
- Off-Label Drug Use in Pediatric PatientsClinical Pharmacology & Therapeutics, 2012
- Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literatureEuropean Journal of Clinical Pharmacology, 2011
- Drug utilization and off-label drug use among Spanish emergency room paediatric patientsEuropean Journal of Clinical Pharmacology, 2009